Please assess the completion status of the following clinical trial:

Trial Title: Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Eosinophilic fasciitis as defined by clinical judgement of an expert,~* Histologically confirmed with a skin-fascia-muscle biopsy, and in additon:~  * Either the presence of a modified skin score according to Zachariae of 8 or higher (0-18), regarded as a generalised eosinophilic fasciitis or the presence of severe contractures due to eosinophilic fasciitis lesions.~Exclusion Criteria:~* Age \< 18 yrs~* Contraindications to MTX: AST/ALT level \> 2 times upper limit of normal, WBC count \< 3.5 x 109/l or platelet count \< 150 x 109/l, serum creatinine \> 130 micromol/l or clearance \< 50 ml/min, confirmed by two repeated tests within one month.~* Chronic liver disease, insulin dependant diabetes mellitus, alcohol abuse~* Restrictive pulmonary disease (total lung capacity or vital capacity \< 40% of predicted) or interstitial lung disease (KCO \< 60% of predicted)~* Pregnancy or child bearing potential without adequate contraception~* The presence of any serious co-morbidity or malignancy~* Use of other anti-folate drugs than MTX

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).